Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation.
Lan
L
Kang
Tong
T
Wu
Yu
Y
Tao
Ye
Y
Yuan
Jing
J
He
Yu
Y
Zhang
Tong
T
Luo
Zhaohui
Z
Kou
Shaorong
S
Gao
D000818:Animals; D065150:Cellular Reprogramming; D004318:Doxycycline / Q000494:pharmacology; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D005822:Genetic Vectors / Q000378:metabolism; D057026:Induced Pluripotent Stem Cells / Q000166:cytology / Q000378:metabolism*; D000090062:Kruppel-Like Factor 4; D051741:Kruppel-Like Transcription Factors / Q000235:genetics / Q000378:metabolism; D016086:Lentivirus / Q000235:genetics; D051379:Mice; D050814:Octamer Transcription Factor-3 / Q000235:genetics / Q000378:metabolism; D055748:SOXB1 Transcription Factors / Q000235:genetics / Q000378:metabolism; D057891:Tetraploidy
D000090062:Kruppel-Like Factor 4; D051741:Kruppel-Like Transcription Factors; D050814:Octamer Transcription Factor-3; C494174:Pou5f1 protein, mouse; D055748:SOXB1 Transcription Factors; C527783:Sox2 protein, mouse; D004318:Doxycycline